arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2202.13860physics.bio-phq-bio.QM
收藏

基于动态模式分解的Fisher-Kolmogorov肿瘤生长模型的数据驱动模拟

Data-driven simulation of Fisher-Kolmogorov tumor growth models using Dynamic Mode Decomposition

Alex Viguerie, Malú Grave, Gabriel F. Barros, Guillermo Lorenzo, Alessandro Reali, Alvaro L. G. A. Coutinho

摘要:

通过常规收集的临床和成像数据对癌症的器官尺度生物力学模型进行个性化的计算机模拟,能够获得对患者受影响器官解剖结构的肿瘤生长和治疗反应的患者特异性预测。这些患者特定的计算预测已被认为是个性化癌症临床管理和为个体患者获得最佳治疗计划的有前途的方法,这构成了临床肿瘤学中的及时和关键需求。然而,底层时空模型的计算机模拟可能需要高昂的计算成本,这对成功开发用于个性化肿瘤预测的临床可行的计算技术构成了障碍。为了解决这个问题,在这里,我们建议利用动态模式分解(DMD)来构建癌症模型的低维表示,并加速其模拟。DMD是一种基于奇异值分解的无监督机器学习方法,已被证明在许多应用中作为预测和诊断工具都很有用。我们表明DMD可以应用于Fisher-Kolmogorov模型,该模型构成了一个既定的配方,以代表未经治疗的实体瘤生长,可以进一步适应其他相关的癌症现象。我们的研究结果表明,该模型在临床相关参数空间上的DMD实现可以产生令人印象深刻的预测,尽管训练时间很短,但中短期误差仍低于1%,长期误差仍低于20%。我们认为,这种数据驱动的方法有可能大大减少癌症模型的个性化模拟的计算开销,从而促进肿瘤预测,参数识别,不确定性量化和治疗优化。

英文摘要:

The computer simulation of organ-scale biomechanistic models of cancer personalized via routinely collected clinical and imaging data enables to obtain patient-specific predictions of tumor growth and treatment response over the anatomy of the patient's affected organ. These patient-specific computational forecasts have been regarded as a promising approach to personalize the clinical management of cancer and derive optimal treatment plans for individual patients, which constitute timely and critical needs in clinical oncology. However, the computer simulation of the underlying spatiotemporal models can entail a prohibitive computational cost, which constitutes a barrier to the successful development of clinically-actionable computational technologies for personalized tumor forecasting. To address this issue, here we propose to utilize Dynamic-Mode Decomposition (DMD) to construct a low-dimensional representation of cancer models and accelerate their simulation. DMD is an unsupervised machine learning method based on the singular value decomposition that has proven useful in many applications as both a predictive and a diagnostic tool. We show that DMD may be applied to Fisher-Kolmogorov models, which constitute an established formulation to represent untreated solid tumor growth that can further accommodate other relevant cancer phenomena. Our results show that a DMD implementation of this model over a clinically-relevant parameter space can yield impressive predictions, with short to medium-term errors remaining under 1% and long-term errors remaining under 20%, despite very short training periods. We posit that this data-driven approach has the potential to greatly reduce the computational overhead of personalized simulations of cancer models, thereby facilitating tumor forecasting, parameter identification, uncertainty quantification, and treatment optimization.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑